Inventor · disambiguated record
Igor E. Bondarev
Also filed as: BONDAREV IGOR E
6 granted patents·6 pending applications·21 citations·filing 2004–2015
80Inventor score
Top patents by PatentIndex Score
12 records- 0188US8580753B2Modulation of telomere length in telomerase positive cells and cancer therapyBONDAREV IGOR E·Filed 2012·Granted Nov 12, 2013·8 cites·32 claims
- 0283US7741296B2Modulation of telomere length in telomerase positive cells and cancer therapyBONDAREV IGOR E·Filed 2006·Granted Jun 22, 2010·3 cites·20 claims
- 0380US8097595B2Modulation of telomere length in telomerase positive cells and cancer therapyBONDAREV IGOR E·Filed 2010·Granted Jan 17, 2012·5 cites·38 claims
- 0476US8778906B2Modulation of line-1 reverse transcriptaseBONDAREV IGOR E·Filed 2008·Granted Jul 15, 2014·4 cites·27 claims
- 0569US8609623B2Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancerBONDAREV IGOR E·Filed 2006·Granted Dec 17, 2013·1 cites·18 claims
- 0656US2015094215A1Modulation of line-1 reverse transcriptaseALT SOLUTIONS INC·Filed 2014·Application pending·0 cites
- 0752US2005113324A1Modulation of line-1 reverse transcriptaseFiled 2004·Application pending·0 cites
- 0852US2014065072A1Modulation of Telomere Length in Telomerase Positive Cells and Cancer TherapyALT SOLUTIONS INC·Filed 2013·Application pending·0 cites
- 0952US2009099060A1Modulation of line-1 reverse transcriptaseBONDAREV IGOR E·Filed 2005·Application pending·0 cites
- 1047US9078901B2Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancerALT SOLUTIONS INC·Filed 2013·Granted Jul 14, 2015·0 cites·20 claims
- 1145US2016000937A1Modulation of telomere length in telomerase positive cells and cancer therapyALT SOLUTIONS INC·Filed 2015·Application pending·0 cites
- 1245US2009203636A1Prevention and Treatment of Cancer and Other DiseasesBONDAREV IGOR E·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Igor E. Bondarev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →